THE ROLE OF GENDER IN SALT-INDUCED HYPERTENSION

REFERENCES

• Dahl L. K., Knudsen K. D., Ohanian E. V., Muirhead M., Tuthill R. Role of gonads in hypertension prone rats. J. Exp. Med. 1975; 142: 748–759
   PubMed Web of Science ®Google Scholar
• Lerner D. J., Kannel W. B. Patterns of coronary heart disease morbidity in the sexes: a 26 year follow-up of the Framingham population. Amer. Heart J. 1986; 111: 383–390
   PubMed Web of Science ®Google Scholar
• Nabulsi A. A., Folsom A. R., White A., Patsch W., Heiss G., Wu K. K., Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women. N. Engl. J. Med. 1993; 328: 1069–1075
   PubMed Web of Science ®Google Scholar
• Gilligan D. M., Quyyumi A. A., Cannon R. O. Effects of physiological levels of estrogen on cornonary vasomotor function in postmenopausal women. Circ. 1994; 89: 2545–2551
   PubMed Web of Science ®Google Scholar
• Iams S. G., Wexler B. C. Inhibition of the development of spontaneous hypertension in SH rats by gonadectomy or estradiol. J. Lab. Clin. Med. 1979; 10: 608–616
   Google Scholar
• Hinojosa-Laborde C., Lange D. L., Haywood J. R. Role of female sex hormones in the development and reversal of Dahl hypertension. Hypertension 2000; 35: 484–489
   PubMed Web of Science ®Google Scholar
• Bayorh M. A., Ogbolu E. C., Williams E., Thierry-Palmer M., Sanford G., Emmett N., Harris-Hooker S., Socci R. R., Chu T. C., Chenault V. M. Possible mechanisms of salt-induced hypertension in Dahl salt-sensitive rats. Physiol. Behav. 1998; 65: 563–568
   PubMed Web of Science ®Google Scholar
• Chen P. Y., Sanders P. W. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993; 22: 812–818
   PubMed Web of Science ®Google Scholar
• Patel A., Layne S., Watts D., Kirchner K. A. L-Arginine administration normalizes pressure natriuresis in the hypertensive Dahl rats. Hypertension 1993; 22: 863–869
   PubMed Web of Science ®Google Scholar
• Simchon S., Manger W., Blumberg G., Brensilver J., Cortell S. Impaired renal vasodilation and urinary cGMP excretion in Dahl salt-sensitive rats. Hypertension 1996; 27: 653–637
   PubMed Web of Science ®Google Scholar
• Bayorh M. A., Williams E., Thierry-Palmer M., Sanford G., Emmett N., Harris-Hooker S., Socci R. R., Chu T. C. Enhanced nitric oxide synthesis reverses salt-induced alterations in blood flow and cGMP levels. Clin. Exper. Hypertension 1999; 21: 333–352
   PubMed Web of Science ®Google Scholar
• Rudd M. A., Trolliet M., Hope S., Scribner A. W., Daumerie G., Toolan G., Cloutier T., Loscalzo J. Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition. Amer. J. Physiol. 1999; 277: H732–H739
   Google Scholar
• Heuze-Joubert I. H., Mennecier P., Simonet S., Laubie M., Verbbeuren T. J. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated rat kidney. Eur. J. Pharmacol. 1992; 220: 161–171
   Google Scholar
• Warren J. B., Coughlan M. L., Williams T. J. Endotoxin-induced vasodilation in anesthetized rat skin involves nitric oxide and prostaglandin synthesis. Br. J. Pharmacol. 1992; 106: 953–957
   PubMed Web of Science ®Google Scholar
• Mark A. L. Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension 1991; 17: I-86–I-90
   Google Scholar
• Baldessarini R. J., Kopin I. J. The effects of drugs on the release of norepinephrine-H3 from central nervous system tissues by electrical stimulation in vitro. J. Pharmacol. Exper. Thera. 1967; 156: 31–38
   PubMed Web of Science ®Google Scholar
• Crofton J. T., Share L. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 1997; 29: 494–499
   PubMed Web of Science ®Google Scholar
• Tobian L., Ganguli M., Goto A., Ikeda T., Johnson M. A., Iwai J. The influence of renal prostaglandins, central nervous system and NaCl on hypertension of Dahl S rats. Clin. Exp. Pharmacol. Physiol. 1982; 9: 341–353
   PubMed Web of Science ®Google Scholar
• Mancia G. The sympathetic nervous system in hypertension. J. Hypertension 1997; 15: 1553–1565
   PubMed Web of Science ®Google Scholar
• Patel M. B., Stewart J. M., Loud A. V., Anversa P., Wang J., Fiegel L., Hintze T. H. Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation 1991; 84: 2091–2100
   PubMed Web of Science ®Google Scholar
• Sen S., Tarazi R. C., Khairallah P., Bumpus M. Cardiac hypertrophy in spontaneously hypertensive rats. Circ. Res. 1974; 35: 775–781
   PubMed Web of Science ®Google Scholar
• Kauser K., Rubanyi G. M. Gender difference in bioassayable endothelium-derived nitric oxide release from isolated rat aortae. Amer. J. Physiol. 1994; 267: H2311–H2317
   PubMed Web of Science ®Google Scholar
• Myers S. I., Turnage R. H., Bartula L., Kalley B., Meng Y. Estrogen increases male aortic endothelial cell (RAEC) PGI2 release. Prostaglandins Leukot. Essent. Fatty Acids 1996; 54: 403–409
   PubMed Web of Science ®Google Scholar
• Wellman G. C., Bonev A. D., Nelson M. T., Brayden J. E. Gender differences in coronary artery diameter involve estrogen, nitric oxide and Ca2+-dependent K+ channels. Circ. Res. 1996; 79: 1024–1030
   PubMed Web of Science ®Google Scholar
• Rosselli M., Imthurn B., Keller P. J., Jackson E. K., Dubey R. K. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension 1995; 25: 848–853
   PubMed Web of Science ®Google Scholar
• Fogelberg M., Vesterqvist O., Diczfalusy U., Henriksson P. Experimental atherosclerosis: Effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation. Eur. J. Clin. Invest. 1990; 20: 105–110
   PubMed Web of Science ®Google Scholar
• Kauser K., Rubanyi G. M. Gender difference in endothelial dysfunction in aorta of spontaneously hypertensive rats. Hypertension 1995; 25: 517–523
   PubMed Web of Science ®Google Scholar
• McIntyre M., Hamilton C. A., Rees D. D., Reid J. L., Dominiczak A. F. Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension 1997; 30: 1517–1524
   PubMed Web of Science ®Google Scholar
• Greenberg S. S., Diecke F. P., Cantor E., Peevy K., Tanaka T. P. Inhibition of sympathetic neurotransmitter release by modulators of cyclic GMP in canine vascular smooth muscle. Eur. J. Pharmacol. 1990; 187: 409–423
   PubMed Web of Science ®Google Scholar
• Mantelli L., Amerini S., Rubino A., Ledda F. Prejunctional prostanoid receptors on cardiac adrenergic terminals may belong to EP3 subtype. Br. J. Pharmacol. 1991; 102: 573–576
   PubMed Web of Science ®Google Scholar
• Reinmann W., Steinhauer H. B., Hedler L., Starke K., Hertting G. Effect of prostaglandin D2, E2 and F2 on catecholaime release from slices of rat and rabbit rain. Eur. J. Pharmacol. 1981; 69: 421–427
   PubMed Web of Science ®Google Scholar
• Jensen T. J., Nedergaard O. A. Modulation of norepinephrine release from sympathetic neurons of the rabbit aorta by prejunctional prostanoid receptors. J. Pharmacol. Exper. Thera. 1999; 291: 7–11
   PubMed Web of Science ®Google Scholar
• Matrougui K., Maclouf J., Lévy B. I., Henrion D. Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension 1997; 30: 942–947
   PubMed Web of Science ®Google Scholar